These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8783616)

  • 1. Nitric oxide in hemodialysis and its relation to hypotensive episodes.
    Patrikarea A; Stamatelou K; Ntaountaki I; Papadakis JT
    Contrib Nephrol; 1996; 119():208-11. PubMed ID: 8783616
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of nitric oxide in hypotension during hemodialysis.
    Nakayama M; Kawaguchi Y; Numata M; Hasegawa T; Hosoya T
    Nephron; 1998 Aug; 79(4):490-1. PubMed ID: 9689175
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis.
    Nishimura M; Takahashi H; Maruyama K; Ohtsuka K; Nanbu A; Hara K; Yoshimura M
    Am J Kidney Dis; 1998 May; 31(5):809-17. PubMed ID: 9590191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nitric oxide production in patients with hypotension during hemodialysis.
    Yokokawa K; Mankus R; Saklayen MG; Kohno M; Yasunari K; Minami M; Kano H; Horio T; Takeda T; Mandel AK
    Ann Intern Med; 1995 Jul; 123(1):35-7. PubMed ID: 7762912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.
    Raj DS; Vincent B; Simpson K; Sato E; Jones KL; Welbourne TC; Levi M; Shah V; Blandon P; Zager P; Robbins RA
    Kidney Int; 2002 Feb; 61(2):697-704. PubMed ID: 11849413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications for the role of endogenous nitric oxide inhibitors in hemodialysis hypotension.
    Kang ES; Acchiardo SR; Kang AH
    Free Radic Res; 2001 Oct; 35(4):341-65. PubMed ID: 11697132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension.
    Peer G; Itzhakov E; Wollman Y; Chernihovsky T; Grosskopf I; Segev D; Silverberg D; Blum M; Schwartz D; Iaina A
    Nephrol Dial Transplant; 2001 Jul; 16(7):1436-41. PubMed ID: 11427637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
    Kang ES; Miles DE; Tevlin MT; Cates TB; Acchiardo SR
    Am J Med Sci; 2001 Feb; 321(2):113-23. PubMed ID: 11217813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated secretion of arginine vasopressin during hemodialysis in patients with hemodialysis hypotension.
    Nakayama M; Yamada K; Nakano H; Miura Y; Tuchida H; Kawaguchi Y
    Nephron; 1998 Aug; 79(4):488-9. PubMed ID: 9689174
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic hypotension in the dialysis patient.
    Cases A; Coll E
    J Nephrol; 2002; 15(4):331-5. PubMed ID: 12243360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in haemodialysis hypotension.
    Nishimura M; Takahashi H; Yoshimura M
    Acta Physiol Scand; 2000 Jan; 168(1):181-6. PubMed ID: 10691798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
    Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
    Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.
    Kang ES; Tevlin MT; Wang YB; Chiang TM; Cardenas R; Myers LK; Acchiardo SR
    Am J Med Sci; 1999 Jan; 317(1):9-21. PubMed ID: 9892267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide production with PMMA membrane.
    Amore A; Coppo R
    Contrib Nephrol; 1999; 125():182-96. PubMed ID: 9895440
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodialysis-related hypotension].
    Tsubakihara Y
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():225-36. PubMed ID: 15250300
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of red cell transfusion on hemodialysis-related hypotension.
    Sherman RA; Torres F; Cody RP
    Am J Kidney Dis; 1988 Jan; 11(1):33-5. PubMed ID: 3337097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of sodium profiling on blood volume and intradialytic hypotension in patients on maintenance hemodialysis.
    Kaczmarczyk I; Kraśniak A; Drozdz M; Chowaniec E; Gajda M; Radziszewski A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):476-82. PubMed ID: 18409348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents.
    Coll E; Larrousse M; de la Sierra A; Collado S; Jiménez W; Cases A
    Clin Nephrol; 2008 Feb; 69(2):114-20. PubMed ID: 18365352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamical study on patients with hemodialysis-induced hypotension.
    Shimizu M; Endo K; Marumo F; Noro C; Kikawada R
    Proc Clin Dial Transplant Forum; 1979; 9():108-9. PubMed ID: 552032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.